Precigen (PGEN): Kirk converts preferred, sells 5.0M shares — 39.4% stake
Randal J. Kirk and related entities updated their Schedule 13D/A for Precigen, Inc. (PGEN).
Rhea-AI Filing Summary
Randal J. Kirk and related entities updated their Schedule 13D/A for Precigen, Inc. (PGEN). The filing discloses that on September 17, 2025 the R.J. Kirk Declaration of Trust converted 25,000 shares of 8.00% Series A Convertible Perpetual Preferred Stock into 17,385,257 shares of Common Stock. Between September 18–19, 2025, Kapital Joe, LLC (under common control) sold 5,000,252 shares in open-market transactions for approximately $18,648,905.62. The cover-page holdings show Mr. Kirk with beneficial ownership of 146,295,359 shares (39.4%), RJ DOT 98,831,434 shares (26.6%), Sunset 2020 LLC 16,406,828 shares (4.4%), and Third Security, LLC 27,454,284 shares (7.4%). The filing also notes exercisable warrants (16,666,667) and options (906,512) included in Mr. Kirk's beneficial ownership calculation and incorporates prior amendments.
Positive
- Conversion transparency: The filing clearly discloses conversion of Preferred Stock into 17,385,257 shares by RJ DOT.
- Full disclosure of sales: Kapital Joe's open-market sales of 5,000,252 shares for ~$18.65M are explicitly reported.
- Comprehensive ownership detail: Reporting pages disclose aggregate beneficial ownership and include exercisable warrants and options in calculations.
Negative
- Share dilution: The conversion and the filing note an increase in shares outstanding used for percentage calculations (company reported conversion of 54,937,411 shares overall), which dilutes existing holders.
- Affiliate sell-down: Kapital Joe's sale of 5.0M shares represents near-term monetization by a Kirk-controlled entity, reducing that affiliate's stake.
Insights
TL;DR: Kirk significantly increased reported common shares via conversion while a related entity sold 5.0M shares, modestly monetizing holdings.
The conversion of Preferred Stock into 17.4 million common shares materially increases Kirk-affiliated common shares outstanding and is disclosed as an investment action by RJ DOT. The near-term sale of 5.0 million shares by Kapital Joe generated about $18.65 million of proceeds, reducing that affiliate's stake. Beneficial ownership percentages reported reflect inclusion of convertible securities and exercisable warrants/options, which could further affect dilution if exercised. The filing is a standard 13D/A amendment providing transparency on ownership and recent transactions.
TL;DR: The amendment transparently updates conversions and market sales but signals active disposition and potential future dilution from exercisable securities.
The Schedule 13D/A documents a conversion event and subsequent open-market sales by an affiliate under common control. Inclusion of 16,666,667 exercisable warrants and 906,512 options in the ownership calculation is notable for governance because exercise or conversion would change voting power and economic interest. The joint filing agreement and repeated amendments reflect ongoing reporting compliance by the Reporting Persons.
FAQ
What did Randal J. Kirk disclose in the PGEN Schedule 13D/A?
How much of Precigen (PGEN) does Mr. Kirk beneficially own after the amendment?
Are there additional convertible or exercisable securities disclosed for PGEN?
When were the conversion and the sales reported?
How were the proceeds from the Kapital Joe sales reported?
AI-generated analysis. How Rhea-AI works. Not financial advice.